Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake
Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved
Secondary outcomes related to treatment satisfaction, well-being, and lifestyle
This is especially important because changes in dopamine levels can affect how people feel emotionally, how they handle cravings, and even their overall well-being
Free T3 (Triiodothyronine): The "active" hormone that actually manages your metabolism
Mechanisms underlying cardiovascular effects of incretin therapy In addition to glycemic effects, GLP-1RAs also favorably modulate multiple cardiovascular risk factors via acting on a variety of organ systems